A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis

A Pacifico, R Daidone, Ketty Peris

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Betamethasone valerate (BMV) is a medium-potency corticosteroid commonly used for the treatment of chronic psoriasis. Although occlusion has been shown to enhance the efficacy of BMV treatment, no ready-to-use occlusive BMV formulation is currently approved for the market.
Original languageEnglish
Pages (from-to)153-157
Number of pages5
JournalJournal of the European Academy of Dermatology and Venereology
Volume20
DOIs
Publication statusPublished - 2006

Keywords

  • Administration, Cutaneous
  • Adult
  • Aged
  • Betamethasone Valerate
  • Chemistry, Pharmaceutical
  • Double-Blind Method
  • Female
  • Glucocorticoids
  • Humans
  • Male
  • Middle Aged
  • Occlusive Dressings
  • Prospective Studies
  • Psoriasis
  • Questionnaires
  • Severity of Illness Index
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis'. Together they form a unique fingerprint.

Cite this